20. Parkinson's and Alzheimer's Meds Flashcards

1
Q

chronic neurological disorder w/ degeneration of dopaminergic neurons leading to a lack of dopamine and imbalance of NTs dopamine and ACh (more excitatory ACh than inhibitory dopamine)

A

Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

frequently occurs as an adverse reaction to various drugs, carbon monoxide, manganese, or disorders (encephalitis, stroke, or trauma)

A

Pseudoparkinsonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

symptoms of Parkinson’s disease

A
  • involuntary tremors of limbs (triad)
  • rigidity of muscles (triad)
  • bradykinesia (triad)
  • postural changes (head and chest forward)
  • shuffling walk
  • lack of facial expression
  • pill-rolling motions of hands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

5 treatment regimens for Parkinson’s disease

A
  • anticholinergics (block cholinergic receptors)
  • dopamine replacements (stimulate dopamine receptors)
  • dopamine agonists (stimulate dopamine receptors)
  • MAO-B inhibitors (inhibits MAO-B enzyme that interferes w/ dopamine)
  • COMT inhibitors (inhibits COMT enzyme that inactivates dopamine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what type of drug is Benztropine Mesylate

A

anticholinergic (antiparkinson)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of bneztropine

A
  • blocks cholinergic (muscarinic) receptors
  • decreases ACh to reduce excess cholinergic activity
  • blocks dopamine reuptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

uses of benztropine

A
  • helps decrease muscle stiffness, sweating, and production of saliva
  • improves walking ability in people w/ Parkinson’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

administration of benztropine

A

PO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

side effects/adverse effects of benztropine

A
  • drowsiness
  • dizziness
  • constipation/illeus
  • flushing
  • nausea
  • nervousness
  • blurred vision
  • dry mouth
  • urinary retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

contraindications for benztropine

A
  • glaucoma
  • myasthenia gravis
  • tardive dysinesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pt teaching for benztropine

A
  • don’t drive car or operate machinery until you know how the drug affects you
  • avoid long term sun exposure (drug can cause skin sensitivity to sunlight)
  • avoid alcohol
  • hard candy (sour) can help w/ dry mouth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what type of drug is carbidopa-levodopa

A

dopaminergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of carbidopa-levodopa

A
  • transmission of levodopa to brain cells for conversion to dopamine
  • carbidopa blocks conversion of levodopa to dopamine in intestine and peripheral tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

uses of carbidopa-levodopa

A
  • treat Parkinson’s disease
  • Parkinsonism
  • relieves tremors and rigidity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

side effects of carbidopa-levodopa

A
  • anorexia
  • N/V
  • dysphagia
  • dyskinesia
  • erythema
  • fatigue
  • dizziness
  • HA
  • dry mouth
  • constipation
  • bitter taste
  • twitching
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

adverse effects of carbidopa-levodopa

A
  • blood dyscrasia
  • cardia dysrhythmias
  • abrupt discontinuation can cause neuroleptic malignant syndrome
17
Q

administration of carbidopa-levodopa

A

take w/ food to decrease GI upset (can slow absorption rate)

18
Q

pt teaching

A
  • don’t discontinue abruptly
  • urine may be discolored or appear dark/stain clothes (harmless)
  • don’t chew or crush ER tablets
19
Q

what type of drug is tolcapone (Tasmar)

A

catechol-o-methyltransferase inhibitor

20
Q

MOA of tolcapone

A

inhibits metabolism of levodopa in the bloodstream -> increases duration of drug in body

21
Q

use of tolcapone

A

idiopathic PD

22
Q

administration of tolcapone

A

only in conjunction w/ levodopa/carbidopa

23
Q

Adverse effects of tolcapone

A
  • fulminant liver failure
  • disorientation
  • confusion
  • hallucinations
  • psychosis
24
Q

what to monitor for w/ tolcapone

A
  • acute fulminant liver failure -> LFTs initially and Q 2 weeks
25
Q

contraindications for tolcapone

A
  • liver disease
  • non traumatic rhabodomylosis
  • hyperpyrexia (high fever)
  • confusion
26
Q

pathophysiology of Alzheimer’s disease

A
  • cholinergic neuron degeneration and acetylcholine deficiency
  • neuritic plaques form
  • neurofibrillary tangles are in neurons
27
Q

what is the goal of Alzheimer’s therapy

A

slow memory and cognition loss

28
Q

what type of drug is Rivastigmine

A

acetylcholinesterase (AChE) inhibitor

29
Q

MOA of rivastigmine

A

elevates ACh concentration

30
Q

use of rivastigmine

A

improves milk to moderate memory loss in Alzheimer’s disease

31
Q

side effects of rivastigmine

A
  • ABD pain
  • anorexia
  • N/V/D
  • dehydration
  • weight loss
  • weakness
  • dizziness
  • drowsiness
  • depression
  • peripheral edema
  • dry mouth
  • nystagmus
  • shakiness (tremor)
  • HA
32
Q

adverse effects of rivastigmine

A
  • seizures
  • bradycardia
  • orthostatic hypotension
  • cataracts
  • MI
  • heart failure
  • hepatotoxicity
  • suicidal ideation
  • SJS
33
Q

administration of rivastigmine

A
  • oral: BID w/ food (peak onset 1 hour)

- transdermal patch: applied daily to clean skin same time each day with rotating sites (peak 8-16 hours)

34
Q

contraindications of rivastigmine

A
  • liver and renal diseases
  • urinary tract obstruction
  • orthostatic hypotension
  • bradycardia
  • active GI bleed
  • asthma/COPD
  • peptic ulcer disease
  • surgery
  • smoking
35
Q

pt teaching for rivastigmine

A
  • increases effects of general anesthetics
  • NSAIDs increase GI effects
  • tobacco increases clearance
  • TCAs decrease effects
  • don’t double dose or stop abruptly